[1]
G. Bendelman et al., “What’s new in the treatment of amyloidosis? Part 2: Cardiomyopathy due to transthyretin amyloidosis”, Rev Hosp Ital B.Aires, vol. 44, no. 1, p. e0000353, Mar. 2024, doi: 10.51987/revhospitalbaires.v44i1.353.